Acute HIV Infection Diagnosis and Management

Clinical Presentation and Diagnosis

• Clinicians should maintain a high level of suspicion for acute HIV infection in all patients who have a compatible clinical syndrome and who report recent high-risk behavior, according to the Centers for Disease Control and Prevention (CDC) 1, 2
• A plasma RNA test should be used in conjunction with an HIV antibody test to diagnose acute HIV infection, as recommended by the CDC 1, 2
• An estimated 40-90% of persons who acquire HIV infection will experience symptoms of acute HIV infection, which resemble influenza, infectious mononucleosis, and other viral illnesses, making clinical recognition essential, as stated by the CDC 3
• Viremia occurs acutely after infection before the detection of a specific immune response; an indeterminate antibody test may occur when a person is in the process of seroconversion, according to the CDC 4, 5
• HIV RNA in plasma can be detected by using sensitive PCR or bDNA assays together with a negative or indeterminate HIV antibody test, providing laboratory evidence of acute HIV infection, as recommended by the CDC 4, 5

Importance of Early Diagnosis and Treatment

• Delaying diagnosis of acute HIV infection has serious consequences for both the patient and public health, as stated by the CDC 3
• Identifying primary HIV infection can reduce the spread of HIV that might otherwise occur during the acute phase of HIV disease, when viral loads are extremely high and transmission risk is greatest, according to the CDC 3
• Many experts would recommend antiretroviral therapy for all patients who demonstrate laboratory evidence of acute HIV infection, and early treatment may suppress initial viral replication, decrease severity of acute disease, and potentially alter the viral set-point, as recommended by the CDC 4, 5
• If HIV RNA testing is positive, the patient should be referred immediately to an HIV specialist for consideration of antiretroviral therapy, as treatment of acute HIV infection may provide clinical benefit, according to the CDC 4, 5

Testing and Referral Guidelines

• HIV testing should be performed on any exposed person who has an illness compatible with an acute retroviral syndrome, regardless of the interval since exposure, as recommended by the CDC 6
• The routine use of direct virus assays to detect infection is specifically recommended when acute HIV infection is suspected, despite not being recommended for routine screening, according to the CDC 1, 2
• If clinical suspicion exists for acute HIV infection, HIV RNA testing should be performed and PrEP withheld pending test results; administration of a fully suppressive ART regimen (early treatment) is recommended in cases where clinical suspicion exists, as stated by the American Medical Association (AMA) 7

HIV Antigen Detection Recommendations

Primary Testing Recommendation

• The American Academy of Family Physicians and the International Antiviral Society-USA Panel recommend using a fourth-generation combination HIV antibody/antigen (p24) immunoassay as the initial screening test for high-risk adults and adolescents, which detects both HIV antibodies and p24 antigen simultaneously, with sensitivity and specificity greater than 99.5% 8, 9
• The International Antiviral Society-USA Panel specifically recommends screening with assays that can detect recent HIV infection, explicitly naming the combined HIV antibody and antigen test as optimal, reducing the diagnostic window period by detecting p24 antigen during acute infection before antibodies develop 9

When to Use HIV RNA Testing

• The CDC recommends adding HIV RNA testing (plasma RNA assay using PCR or bDNA) when acute HIV infection is clinically suspected, particularly in patients with compatible symptoms and recent high-risk behavior, to diagnose acute HIV infection, as antibody tests may still be negative during this critical period 10

Testing Algorithm for High-Risk Populations

• The American Academy of Family Physicians recommends using fourth-generation combination HIV antibody/p24 antigen immunoassay for all routine screening, with initial positive results requiring confirmation with Western blot or immunofluorescent assay 8, 9

Screening Frequency for High-Risk Groups

• The American Medical Association and the CDC recommend screening every 3 months for men who have sex with men, transgender persons, people who inject drugs, and those newly diagnosed with other STIs, as long as risk continues, and at least annual screening for persons at very high risk, including injection drug users, those with multiple sex partners, and those in high-prevalence settings 8, 9, 10

Acute HIV Infection: Diagnosis and Management (CDC Guidelines)

Clinical Presentation and Diagnosis

• Fever, muscle aches, and sore throat occur in 40–90 % of individuals with acute HIV infection. 11, 12
• A transient, pruritic genital ulcer can accompany primary infection and is consistent with the acute chancroid‑like lesion described in early HIV disease. 13
• Symptom onset typically ≈10 days after exposure, aligning with the usual first‑week presentation window of acute retroviral syndrome. 13, 12

Laboratory Confirmation

• Viral RNA testing (PCR or bDNA) should be performed urgently because ELISA may be positive during seroconversion, and antibody results can be indeterminate. 13
• Positive plasma HIV‑RNA together with a negative or indeterminate antibody test provides definitive laboratory evidence of acute infection. 14, 11
• When RNA testing is unavailable, a p24 antigen assay can be used, but a negative result does not exclude acute infection. 14, 11
• High clinical suspicion (recent risk exposure and compatible symptoms) mandates immediate RNA testing. 14, 11
• All positive ELISA results must be confirmed with Western blot or immunofluorescence before a definitive diagnosis is made. 13, 12
• During the seroconversion window, Western blot may yield indeterminate patterns. 14, 11

Antiretroviral Treatment Recommendations

• CDC recommends initiating antiretroviral therapy (ART) for every patient with laboratory‑confirmed acute HIV infection. 14
• The preferred regimen consists of two nucleoside reverse transcriptase inhibitors (NRTIs) plus a potent protease inhibitor. 14, 13, 12

Benefits of Early ART

• Early ART suppresses initial viral replication, reduces the severity of the acute illness, and may lower the viral set‑point. 14
• Prompt treatment can delay the onset of HIV‑related complications. 13, 12
• Initiation of ART in the acute phase may alter the long‑term disease progression rate. 14, 15

Clinical Recognition in Primary Care

• Acute retroviral syndrome is frequently missed in primary‑care settings because its presentation mimics influenza and other viral illnesses. 15, 11
• Clinicians should maintain a high index of suspicion for patients presenting with compatible symptoms and recent risk behavior. 11

Counseling, Follow‑up, and Monitoring

• After diagnosis, immediate counseling on transmission prevention should be provided. 13, 12
• Initiate behavioral, psychosocial, and medical evaluation services to support the patient. 13, 12
• Monitor plasma viral load and CD4⁺ cell count to assess treatment response and disease status. 14, 11
• Patients should be informed that treatment of primary HIV infection is grounded in solid theoretical rationale and supportive clinical data, although the evidence base remains limited. 14, 15